Cita APA (7a ed.)

AU, K., SH, H. A. A., MZ, H., S, F., & P, A. (2013). Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent. Dove Medical Press.

Cita Chicago Style (17a ed.)

AU, Kura, Hussein Al Ali SH, Hussein MZ, Fakurazi S, y Arulselvan P. Development of a Controlled-release Anti-parkinsonian Nanodelivery System Using Levodopa as the Active Agent. Dove Medical Press, 2013.

Cita MLA (8a ed.)

AU, Kura, et al. Development of a Controlled-release Anti-parkinsonian Nanodelivery System Using Levodopa as the Active Agent. Dove Medical Press, 2013.

Precaución: Estas citas no son 100% exactas.